The effects of thymoquinone and genistein treatment on telomerase activity, apoptosis, angiogenesis, and survival in thyroid cancer cell lines | Zendy

Sibel Azizenur Ozturk | Zendy; Ebru Alp | Zendy; Atiye Seda Yar Sağlam | Zendy; Ece Konaç | Zendy; Emine Sevda Menevşe | Zendy

Open Access

The effects of thymoquinone and genistein treatment on telomerase activity, apoptosis, angiogenesis, and survival in thyroid cancer cell lines

Author(s) -

Sibel Azizenur Ozturk,

Ebru Alp,

Atiye Seda Yar Sağlam,

Ece Konaç,

Emine Sevda Menevşe

Publication year - 2017

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.202886

Subject(s) - angiogenesis , survivin , telomerase , cancer research , telomerase reverse transcriptase , follicular thyroid cancer , thyroid cancer , pten , thymoquinone , viability assay , cancer , anaplastic thyroid cancer , vascular endothelial growth factor , medicine , biology , apoptosis , pi3k/akt/mtor pathway , papillary thyroid cancer , biochemistry , vegf receptors , gene , antioxidant

Thyroid cancers (TCs) are the most common endocrine malignancies. There were two problems with the current cancer chemotherapy: the ineffectiveness of treatment due to resistance to cancer cell, and the toxic effect on normal cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research